Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12395034 | 0.94 | MEN1 (0.35) | KMT2AMEN1 | |
| SCHEMBL28299190 | 0.90 | — | — | |
| SCHEMBL10098332 | 0.85 | KMT2A (0.32) | KMT2AALDH1A1LMNAPOLBNPC1 | |
| SCHEMBL26650279 | 0.83 | KMT2A (0.34) | KMT2AALDH1A1LMNAPOLBSMN1; SMN2 | |
| SCHEMBL15699343 | 0.82 | CFTR (0.31) | KMT2AALDH1A1 | |
| SCHEMBL785974 | 0.82 | FKBP1A (0.35) | KMT2AALDH1A1LMNAPOLBKDM4E | |
| SCHEMBL8979423 | 0.81 | MEN1 (0.35) | KMT2AMEN1 | |
| SCHEMBL15697291 | 0.80 | LMNA (0.33) | KMT2AALDH1A1LMNAPOLBKDM4E | |
| SCHEMBL18403032 | 0.80 | KMT2A (0.33) | KMT2AALDH1A1LMNAPOLBKDM4E | |
| SCHEMBL28006840 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4203970-A1 | NOVEL FORMS OF ANTIVIRAL NUCLEOSIDES | Emory University (US) | 2023-07-05 | — | — | EP | disclosed |
| US-9310682-B2 | Positive-type resist composition | CENTRAL GLASS COMPANY, LIMITED (JP) | 2016-04-12 | — | — | US | disclosed |
| US-20140134542-A1 | Positive-Type Resist Composition | CENTRAL GLASS COMPANY, LIMITED (JP) | 2014-05-15 | — | — | US | disclosed |